Radiotherapy for oligometastatic tumor improved the prognosis of patients with non‐small cell lung cancer (NSCLC)-Reference-Cited by-同舟云学术

Radiotherapy for oligometastatic tumor improved the prognosis of patients with non‐small cell lung cancer (NSCLC)

Published:2019-04-07 Issue:5 Volume:10 Page:1136-1140
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thorac Cancer

Author:

Gong Hong‐yun¹^ORCID,Wang Yi¹,Han Guang¹,Song Qi‐bin¹

Affiliation:

1. Department of OncologyCancer Center, Renmin Hospital of Wuhan University Wuhan China

Funder

Natural Science Foundation of Hubei Province

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.13054

Reference17 articles.

1. HowladerN NooneAM KrapchoM et al. SEER Cancer Statistics Review 1975‐2011 National Cancer Institute 2014. [Cited 2011.] Available from URL:http://seer.cancer.gov/statfacts/html/lungb.html.

2. Future Scenarios for the Treatment of Advanced Non-Small Cell Lung Cancer: Focus on Taxane-Containing Regimens

3. Oligometastases.

4. Potentially curative surgical therapy in oligometastatic non‐small cell lung cancer;Plönes T;Dtsch Med Wochenschr,2014

5. Surgical treatment of oligometastatic non-small cell lung cancer

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of electrochemical immunosensor for quantitative detection of non-small cell lung cancer (NSCLC) biomaker YES1;Biosensors and Bioelectronics: X;2023-09

2. Management of Oligometastasis and Oligoprogression in Patients with Epidermal Growth Factor Receptor Mutation-Positive NSCLC in the Era of Third-Generation Tyrosine Kinase Inhibitors;Clinical Lung Cancer;2021-09

3. A novel biosensor for the ultrasensitive detection of the lncRNA biomarker MALAT1 in non-small cell lung cancer;Scientific Reports;2021-02-11

4. Downregulation of long non‑coding RNA LINC‑PINT serves as a diagnostic and prognostic biomarker in patients with non‑small cell lung cancer;Oncology Letters;2021-01-18

5. The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 study;Therapeutic Advances in Medical Oncology;2021-01